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Abstract
Background: Scaling-up and sustaining effective healthcare interventions is essential for improving healthcare;
however, relatively little is known about these processes. In addition to quantitative experimental designs, we need
approaches that use embedded, observational studies on practice-led, naturally occurring scale-up processes. There
are also tensions between having adequately rigorous systems to monitor and evaluate scale-up well that are
proportionate and pragmatic in practice. The study investigated the scale-up of an evidence-based complex
intervention for knee and hip osteoarthritis (ESCAPE-pain) within ‘real-world’ settings by England’s 15 Academic
Health Science Networks (AHSNs).
Methods: A pragmatic evaluation of the scale-up of ESCAPE-pain using the RE-AIM framework to measure Reach,
Effectiveness, Adoption, Implementation and Maintenance. The evaluation used routine monitoring data collected
from April 2014 to December 2018 as part of a national scale-up programme.
Results: Between 2014 and 2018, ESCAPE-pain was adopted by over 110 clinical and non-clinical sites reaching
over 9000 people with osteoarthritis. The programme showed sustained clinical effectiveness (pain, function and
quality of life) and high levels of adherence (78.5% completing 75% of the programme) within a range of real-world
settings. Seven hundred seventy people (physiotherapists and exercise professionals) have been trained to deliver
ESCAPE-pain, and 84.1% of sites have continued to deliver the programme post-implementation.
Conclusions: ESCAPE-pain successfully moved from being an efficacious “research intervention” into an effective
intervention within ‘real-world’ clinical and non-clinical community settings. However, scale-up has been a gradual
process requiring on-going, dedicated resources over 5 years by a national network of Academic Health Science
Networks (AHSNs). Whilst the collection of monitoring and evaluation data is critical in understanding
implementation and scale-up, there remain significant challenges in developing systems sufficiently rigorous,
proportionate and locally acceptable.
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Background
Scaling-up and sustaining evidence-based health inter-
ventions is essential to achieve widespread improve-
ments in the quality of care [1, 2]. However, we have a
poor understanding of how effective complex healthcare
interventions transition from a trial to being imple-
mented at scale-up and sustained in real-world settings
[3–10]. Scale-up needs to be supported by effective
monitoring and evaluation systems [4, 11, 12], but there
are challenges in balancing adequately rigorous systems
to monitor and evaluate scale-up with the need for pro-
portionate and pragmatic approaches [12, 13].
Worldwide, osteoarthritis (OA) is one of the most
prevalent causes of pain and disability, and an estimated
6.83 million people consult for knee or hip OA in the UK
[14, 15]. Yet current management is largely sub-optimal,
and the burden on individuals and society remains high
[16–18]. Although rehabilitation professionals (such as
physical and occupational therapists) understand the need
to implement evidenced-based interventions, their ability
to implement new knowledge into clinical practice re-
mains limited [19–21]. ESCAPE-pain is a complex
evidence-based intervention (EBI) for people with knee or
hip OA that combines structured education and self-
management strategies with an individualised exercise
regime in line with clinical guidelines [22]. Due to the
evidence demonstrating ESCAPE-pain’s clinical and cost
effectiveness [23–26], the programme was adopted
by England’s 15 Academic Health Science Networks
(AHSNs) as a priority for scale-up nationally.
The study aimed to evaluate the scale-up of ESCAPE-
pain as a complex EBI by a network of AHSNs in Eng-
land. Tied to this, we discuss the role of pragmatic data
collection and monitoring in efforts to scale EBIs within
real-world settings.
Methods
Study design
This is a pragmatic evaluation of the scale-up of
ESCAPE-pain using the RE-AIM framework [27, 28]. By
pragmatic, we refer to an approach that is based in prac-
tice (rather than taking a research or theoretical perspec-
tive) using routine monitoring data collected as part of
an AHSNs’ national programme from April 2014 to De-
cember 2018. Table 1 outlines how the RE-AIM frame-
work has been applied within the study to measure
Reach, Effectiveness, Adoption, Implementation and
Maintenance.
ESCAPE-pain programme
ESCAPE-pain is an EBI integrating education and exercise
for people with chronic knee and/or hip pain and OA,
which promotes self-management to improve quality of
life and function [23–26]. People attend in groups of 10–
12 people, twice a week, over 6 weeks (12 sessions). Each
session is led by a trained facilitator and comprises 20–25
min of structured education about OA and self-
management strategies, and 30–45min of exercise. Details
of the programme are available at http://www.escape-pain.
org/. ESCAPE-pain is underpinned by a randomised con-
trolled trial and economic evaluation [23–26].
Scaling-up ESCAPE-pain
NHS England established 15 Academic Health Science
Networks (AHSNs) to help accelerate the spread and
Table 1 Mapping the RE-AIM framework to the study
Domain Description of domain and outcome metric Outcome measure(s) used
Reach Individual level measure of participation. Number of participants and joint affected.
Effectiveness Participants’ outcome or benefits received. KOOS/HOOS^ measuring levels of pain, activities of daily living
and quality of life.
Adoption Setting/location programme was adopted. Type of setting, provider and professional delivering the
programme.
Implementation Factors related to the implementation of the programme. Number of trained facilitators, facilitator feedback on programme
implementation and delivery, self-reported compliance with core
components, participant adherence
Maintenance Whether the programme is maintained (or sustained) post
implementation.
Number of sites delivering ESCAPE-pain post-implementation
^Knee/Hip Injury and Osteoarthritis Outcome Score
Contributions to the literature
 The study has shown quality and reach can be successfully
achieved in a practice-led scale-up process of a complex
intervention outside of a controlled study.
 We found RE-AIM a useful framework for investigating scale-
up, and we describe how it was operationalised within a
pragmatic evaluation.
 The findings provide empirical evidence of the challenges of
developing and embedding systems to monitor and
evaluate practice-led scale-up in the ‘real world’ that are
rigorous and pragmatic.
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adoption on innovation in healthcare. In 2014, ESCAPE-
pain was selected by the AHSN for south London
(Health Innovation Network) as a priority for local
scale-up and was resourced by a small team (i.e. 2–3
project managers and administrative support) led by a
clinical and programme director. In April 2018,
ESCAPE-pain became a national programme for scale-
up supported by all 15 AHSNs across England for a 2-
year period. Scale-up was coordinated by a national
programme manager and dedicated resource (e.g. project
manager, clinical champion) within each AHSN to sup-
port local scale-up.
ESCAPE-pain training course
A 1-day training course was developed to support the
scale-up of ESCAPE-pain to help ensure fidelity to the
core component of the programme and quality. The
course is mandatory for anyone delivering ESCAPE-
pain. Participants learn about the evidence-base and
ethos underpinning ESCAPE-pain, develop a detailed
understanding of the programme’s format, and gain
skills and knowledge to support the implementation and
delivery of the programme.
Data collection
The AHSNs collect routine data to monitor the scale-up
of ESCAPE-pain, which were used to measure outcomes
for each domains of the RE-AIM framework. AHSNs re-
ceive no participant identifiable data, i.e. providers an-
onymise all data prior to submitting it.
Reach—The number of participants attending each co-
hort of ESCAPE-pain and the joint affected (i.e. hip or
knee OA). Demographic data are not collected. There
are no local prevalence data for hip and knee OA avail-
able at the level of individual sites to be able to deter-
mine a reliable denominator. Nationally, there are an
estimated 4.11 million cases of knee OA and 2.46 mil-
lion cases of hip OA [29].
Effectiveness—Pre-/post-programme clinical outcomes
for participants measured using the Knee/Hip Injury and
Osteoarthritis Outcome Score (KOOS and HOOS) sub-
scales of pain, activities of daily living (ADL) and quality
of life (QoL) [30, 31].
Adoption—The number of sites and the type of setting
(e.g. clinical outpatients, non-clinical community), pro-
vider organisation (e.g. NHS, local authority/council,
charity, leisure/fitness centre) and professional (e.g.
physiotherapist, therapy assistant or fitness instructor)
delivering ESCAPE-pain.
Implementation—Self-reported compliance with the
core components of ESCAPE-pain, namely (i) a 1-h ses-
sion twice a week for 6 weeks (i.e. 12 sessions), (ii) each
session contains exercise and structured education, (iii)
the programme follows a cohort structure and (iv) the
programme must be delivered by a trained facilitator. Fa-
cilitators’ self-reported levels of understand of the
programme and ability to implement and deliver the
programme via a routine post-training questionnaire. Par-
ticipant adherence measured by the number of people
completing the programme. Completion was defined as
participants attending 75% of sessions, to match the level
of adherence within the clinical trial [23, 24, 26].
Maintenance—The number of sites continuing or
ceasing to deliver ESCAPE-pain at < 1 year, 1–2 years
and < 2 years post-implementation. It is not possible to
report on maintenance at an individual level because
long-term follow-up data for clinical outcomes are not
collected.
Data analysis
Clinical outcome data were available for 3664 people
with knee OA from 72 sites and 209 people with hip
OA from 33 sites. Only participants with pre- and
post-outcome data were included in the analysis. Data
from all sites were analysed as a single dataset. Paired
t test was used to determine the mean difference for
each subscale, and effect size was calculated using
Cohen’s D. Data were analysed using R v3.5.1. Data
are presented as mean change in KOOS or HOOS
points (confidence intervals, CI), where an increase in
scores indicates an improvement. All other data were
analysed using descriptive statistics.
Results
Reach
Nine thousand one hundred fifty people with hip and knee
OA have participated in the ESCAPE-pain programme be-
tween April 2014 and December 2018 (Fig. 1).
Effectiveness
Pre- and post-rehabilitation data were only available
from 3614 people with knee and 209 people with hip
pain who completed the ESCAPE-pain programme (i.e.
defined as attending ≥ 75% of sessions) (Table 2). Partic-
ipants saw improvements in pain by 7.6 (CI 7.2, 8.1)
KOOS points and 5.2 (CI 3.4, 7) HOOS points, function
8.2 (7.7, 8.7) KOOS and 5.5 (3.5, 7.5) HOOS, and quality
of life 8.1 (7.5, 8.6) KOOS and 5.6 (3.3, 7.9) HOOS
(Table 2). The Western Ontario and McMaster Univer-
sities Osteoarthritis Index (WOMAC) function score
was used as the primary outcome for the ESCAPE-pain
clinical trial [24]. It is possible to calculate the WOMAC
function score from the KOOS [31]. WOMAC function
score showed an improvement of − 5.49 (95% CI − 7.78,
− 3.19, n = 278) in the original trial [24], compared to −
5.38 (− 5.69, − 5.06, n = 3590) in this study.
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Adoption
Between September 2014 and December 2018, 116 sites
were delivering ESCAPE-pain, of which 81 were hospital
outpatient departments and 35 in non-clinical commu-
nity settings (Fig. 1). Following the adoption of ESCAPE-
pain as an AHSN national programme in April 2018,
there were almost twice the number of sites by Decem-
ber 2018. Compared to the original model of delivery
tested within the clinical trial (i.e. physiotherapists
within outpatient departments), the programme has
been adopted across an increasing range of settings, pro-
viders, and profession (Table 3). However, physiothera-
pists delivering ESCAPE-pain in outpatient departments
remain the dominant model (i.e. 70% or 81/116 sites). A
comparison of effectiveness by setting type (i.e. clinical
versus non-clinical) showed no significant different in
outcomes (Table 4), although a smaller dataset was
available for non-clinical settings.
Implementation
Adherence data were available for 6072 participants;
78.5% (n = 4767) of participants completed 75% of ses-
sions. Seven hundred seventy people (or facilitators)
have been trained to deliver ESCAPE-pain (488 physio-
therapists, 282 fitness instructors). Facilitators (n = 665)
agreed (13%) or strongly agreed (87%) they understood
what ESCAPE-pain was and how to implement it, 29%
agreed and 71% strongly agreed they felt able to deliver
ESCAPE-pain. All sites self-report compliance against
the programme’s core 4 components when implement-
ing ESCAPE-pain.
Fig. 1 Cumulative number of participants completing and number of sites delivering ESCAPE-pain
Table 2 Effectiveness of ESCAPE-pain programme for knee and hip OA
Sample size^ Pre-mean (SD) Post-mean (SD) Mean change (95% CI change) Effect size (Cohen’s D)
KOOS Domain
Pain 3614 48.9 (17.3) 56.5 (18.5) 7.6 (7.2, 8.1)** 0.5
Function (ADLs) 3590 53.0 (19.2) 61.1 (20.0) 8.2 (7.7, 8.7)** 0.6
Quality of life 3571 34.0 (18.8) 42.1 (19.8) 8.1 (7.5, 8.6)** 0.5
HOOS Domain
Pain 209 49.5 (18.4) 54.7(20.5) 5.2 (3.4, 7.0)** 0.4
Function (ADLs) 205 53.7 (20.2) 59.2 (20.8) 5.5 (3.5, 7.5)** 0.4
Quality of life 203 39.7 (21.1) 45.2 (20.5) 5.6 (3.3, 7.9)** 0.3
KOOS/HOOS Knee/Hip Injury and Osteoarthritis Outcome Score, ADLs activities of daily living, SD standard deviation, CI confidence interval
^Number of participants with complete datasets (i.e. all sections of the KOOS/HOOS completed before and after completing the programme) out of a total of
9150 people completing the programme
**p < 0.001
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Maintenance
As of December 2018, 84.1% of sites continue to de-
liver ESCAPE-pain post-implementation (116 out of a
total of 138 sites). Table 5 shows the number of sites
delivering/ceasing ESCAPE-pain after the programme
was implemented by three time categories (i.e. < 1,
1–2 and > 2 years). Of all the sites that have imple-
mented ESCAPE-pain (n = 138), it was stopped after
less than 1 year by 11 (8%) sites. Of those sites deliv-
ering ESCAPE-pain at December 2018 (n = 116), it
has been delivered for more than 2 years by 24
(20.7%) sites.
Discussion
The widespread implementation of healthcare innova-
tions usually takes many years; many initiatives fail [3]
or are not translated into practice [32]. We used RE-
AIM to evaluate the national scale-up of ESCAPE-pain,
a complex healthcare intervention for knee and hip OA,
by England’s 15 Academic Health Science Networks
(AHSNs).
Since 2014, ESCAPE-pain has been adopted in over
110 sites, reaching over 9000 people with knee or hip
OA. Whilst this is promising, national prevalence data
for knee (4.11 million) and hip (2.46 million) OA in
England indicate a need for continuing to expand reach
[29]. Although it is delivered predominately by physio-
therapists, a growing number of exercise professionals
are now delivering the programme. It has been adopted
across an expanding range of settings beyond the ori-
ginal model tested in the trial (from NHS outpatient de-
partments to non-clinical community venues), and by a
diverse number of providers and funding arrangements.
This shows that complex healthcare interventions of this
kind can be scaled-up successfully into similar types of
settings and professions and ‘spread-out’ into different
contexts [3, 5].
Monitoring demonstrates that ESCAPE-pain has been
scaled-up; however, it is important to determine what
(exactly) has been implemented (i.e. fidelity) and whether
it is effective (i.e. delivering intended outcomes) [33, 34].
Measuring intervention fidelity and quality within a na-
tional scale-up process has been pragmatic in its ap-
proach. A mandatory 1-day training course was developed
as a strategy to help safeguard that ESCAPE-pain was im-
plemented with fidelity (i.e. by building knowledge and
skills to implement and deliver the programme) [35]. In
addition, all sites implementing ESCAPE-pain were re-
quired to self-report compliance with the programme’s
core components—sites that do not report compliance are
Table 3 Range of settings, providers and practitioners that have delivered ESCAPE-pain
Setting Provider Professional
Physiotherapy dept. NHS (public health provider) Physiotherapist
Leisure/fitness centre NHS (public health provider) Therapy assistant and/or physiotherapist
Leisure/fitness centre Leisure/fitness provider Physiotherapist and/or fitness instructor
Workplace NHS occupational health Physiotherapist
Community centre Third sector Physiotherapist or fitness instructor
Community centre Local authority/town council Physiotherapist and/or fitness instructor
Table 4 Effectiveness of ESCAPE-pain programme for knee and hip OA by setting type
Clinical setting Non-clinical setting
Sample size^ Mean change† (95% CI change) Sample size^ Mean change† (95% CI change)
KOOS domain
Pain 3219 7.68 (6.91, 7.93) 395 7.33 (5.86, 8.80)
Function (ADLs) 3196 8.24 (7.35, 8.35) 394 7.74 (6.33, 9.14)
Quality of life 3177 8.11 (7.21,8.39) 394 7.66 (6.02, 9.31)
HOOS domain
Pain 143 5.40 (3.37, 7.03) 66 4.77 (1.14, 8.40)
Function (ADLs) 140 6.05 (3.53, 7.46) 65 4.30 (0.77, 7.83)
Quality of life 139 6.04 (3.31, 7.87) 64 4.62 (0.35, 8.90)
KOOS/HOOS Knee/Hip Injury and Osteoarthritis Outcome Score, ADLs activities of daily living, CI confidence interval
^Number of participants with complete datasets (i.e. all sections of the KOOS/HOOS completed before and after completing the programme) out of a total of
9150 people completing the programme
†Between-group difference (clinical/non-clinical) for all domains of the HOOS/KOOS was not significant (> 0.05)
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not considered to be delivering ESCAPE-pain. Partici-
pants’ adherence levels were comparable with those ob-
served within the original trial where 55% of participants
completed 10 or more sessions in the ESCAPE-pain group
intervention [23, 24].
Individual level long-term follow-up data are not col-
lected as part of the AHSNs’ national programme, which
means that it is not possible to determine if the self-
management strategies and subsequent benefits delivered
by ESCAPE-pain are maintained by participants. At an or-
ganisational level, the number of sites continuing to de-
liver the programme is high, suggesting it is largely
sustained in practice settings once implemented. There is
debate in the literature about what constitutes sustainabil-
ity (e.g. continued delivery of intervention components,
extent of integration, realisation of outcomes, duration) [8,
34]. In the case of ESCAPE-pain, the majority of sites are
< 1-year post-implementation; therefore, the extent of
long-term sustainability is to be seen.
As interventions move from highly resourced, con-
trolled research conditions into ‘real-world’ settings,
there is a risk effectiveness can be reduced due to the in-
tervention’s essential core components being incorrectly
implemented [34, 36]. Therefore, it is important to con-
tinue to monitor the effectiveness of interventions as
they are implemented in different contexts [12, 13, 34].
Critically for ESCAPE-pain, on-going data collection
demonstrated that the programme’s effectiveness has
been maintained as it spread from a controlled [24],
cloistered trial setting, into very different ‘real-world’
clinical and community settings. However, interpretation
of effectiveness needs to recognise the potential impact
of missing data as people with poorer outcomes may be
underrepresented.
The systematic, on-going monitoring of scale-up dem-
onstrated by AHSNs for ESCAPE-pain is uncommon
[12, 13, 34, 37], despite calls to evaluate the widespread
implementation of self-management programmes for
OA, like ESCAPE-pain [37]. However, data collection
has been difficult as staff (both clinical and non-clinical)
in sites often lack systems to routinely collect data, have
little time and may be unable or reluctant to collect data.
Although the AHSNs have created systems to ease the
burden of collecting and analysing data, there is no way
of enforcing data return. Consequently, data return is
sporadic. All sites have returned data, but not all sites
return data all the time (i.e. as requested quarterly), and
the sites returning data vary overtime. In addition, the
completeness of data returned varies. This results in lim-
itations for reporting scale-up.
Other limitations are that implementation outcomes re-
lied on self-reported and indirect measures (e.g. compli-
ance with core components of ESCAPE-pain, numbers
trained, facilitators’ ability implement and deliver
ESCAPE-pain). However, impartial observation of imple-
mentation across a large number of geographically dis-
persed sites was not feasible. Whilst these measures do
not guarantee the programme was implemented and de-
livered with fidelity or quality, they provided a pragmatic
approach to monitoring. A further challenge going for-
ward is that as the number of sites expands it is essential
that systems and processes underpinning monitoring (e.g.
data collection, quality controls, analysis and reporting)
continue to be rigorous and sustainable (i.e. feasibly
resourced) [12, 13].
Conclusions
An evidence-based complex intervention can be imple-
mented at scale successfully: achieving reach and main-
taining quality. Importantly, ESCAPE-pain’s clinical
effectiveness has been sustained as it has transitioned
into a diverse range of ‘real-world’ settings, beyond those
tested in the original trial. However, scale-up has been a
gradual process requiring on-going, dedicated resources
over 5 years by a national network of AHSNs.
Whilst the collection of data for monitoring and evalu-
ation is critical in understanding implementation and
scale-up, there are significant challenges in developing
systems sufficiently rigorous, proportionate and locally
acceptable.
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